These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 33936088)
1. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer. Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H Front Immunol; 2021; 12():657950. PubMed ID: 33936088 [TBL] [Abstract][Full Text] [Related]
2. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study. Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821 [TBL] [Abstract][Full Text] [Related]
3. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer. Xiao R; Yang M; Tan Y; Ding R; Li D Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952 [TBL] [Abstract][Full Text] [Related]
4. Zhao M; Zhang Q; Song Z; Lei H; Li J; Peng F; Lin S Transl Cancer Res; 2023 Jul; 12(7):1802-1815. PubMed ID: 37588742 [TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
6. A novel immune-related prognostic index for predicting breast cancer overall survival. Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847 [TBL] [Abstract][Full Text] [Related]
7. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma. Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y Front Immunol; 2021; 12():806189. PubMed ID: 35095893 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis. Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150 [TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
10. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma. Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484 [TBL] [Abstract][Full Text] [Related]
11. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment. Chen Y; Meng Z; Zhang L; Liu F Front Immunol; 2021; 12():664845. PubMed ID: 33968066 [TBL] [Abstract][Full Text] [Related]
12. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment. Han W; Huang B; Zhao XY; Shen GL Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786 [TBL] [Abstract][Full Text] [Related]
13. Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO. Wen S; Peng W; Chen Y; Du X; Xia J; Shen B; Zhou G BMC Cancer; 2022 Feb; 22(1):193. PubMed ID: 35184748 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer. Chen T; Yang C; Dou R; Xiong B Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341 [TBL] [Abstract][Full Text] [Related]
15. PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma. Li Z; Zhao R; Yang W; Li C; Huang J; Wen Z; Du G; Jiang L Medicine (Baltimore); 2021 Mar; 100(11):e25008. PubMed ID: 33725976 [TBL] [Abstract][Full Text] [Related]
16. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
17. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer. Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C Gene; 2020 Nov; 761():145049. PubMed ID: 32791092 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer. Zhang X; Shi X; Zhao H; Jia X; Yang Y Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055 [TBL] [Abstract][Full Text] [Related]
19. CD1C is associated with breast cancer prognosis and immune infiltrates. Chen X; Zhang J; Lei X; Yang L; Li W; Zheng L; Zhang S; Ding Y; Shi J; Zhang L; Li J; Tang T; Jia W BMC Cancer; 2023 Feb; 23(1):129. PubMed ID: 36755259 [TBL] [Abstract][Full Text] [Related]
20. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma. Liu D; Yang X; Wu X Front Immunol; 2021; 12():663495. PubMed ID: 34025664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]